NSB 0.00% 3.9¢ neuroscientific biopharmaceuticals ltd

Ann: Investor Webinar Presentation, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 125 Posts.
    lightbulb Created with Sketch. 228
    Available on Youtube here: "Broker Briefing - Free Investor Webinar - 18 November 2021" - for those of us with our fingers on the pulse there was nothing new I could glean that we did not already know, perhaps only this clarifying statement: Results from Phase 1 will take around 9 months to be finalized (MS & AD), and NSB Should be ready to commence Ph2 in MS or AD by Q4 2022... Her use of the word or is a bit confusing, I would've preferred "and"

    @orangehunter not sure what you mean about fast track? Didn't notice any mention of that?
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.